etoposide has been researched along with (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allarà, M; Di Marzo, V; Escobar, R; Faúndez, M; Iturriaga-Vásquez, P; Mella-Raipán, J; Palmieri, V; Pessoa-Mahana, CD; Pessoa-Mahana, H; Romero-Parra, J; Torres, MJ | 1 |
1 other study(ies) available for etoposide and (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
| Article | Year |
|---|---|
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Humans; Molecular Docking Simulation; Protein Binding; Protein Conformation; Receptor, Cannabinoid, CB2; Thiophenes | 2016 |